ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
71 hedge funds and large institutions have $61.3M invested in ChemoCentryx, Inc. in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 11 closing their positions.
123% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 11
1% less funds holding
Funds holding: 72 → 71 (-1)
70% less capital invested
Capital invested by funds: $203M → $61.3M (-$142M)
90% less call options, than puts
Call options by funds: $15K | Put options by funds: $155K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$5.48M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$1.45M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$988K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$574K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$529K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$8.93M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$7.2M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$3.85M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.46M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$194K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
BNP Paribas Financial Markets
Paris,
France
| – | -$43K | -5,314 | Closed |
|
77
Barclays
London,
United Kingdom
| – | -$13.1K | -3,601 | -94% |
|
78
UBS Group
Zurich,
Switzerland
| – | -$17K | -2,118 | Closed |
|
|
CSS
79
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$3K | -346 | Closed |
|
80
Simplex Trading
Chicago,
Illinois
| – | -$772 | -212 | Closed |
|
|
TRCT
81
Tower Research Capital (TRC)
New York
| – | -$2K | -200 | Closed |
|
CCXI Hedge Fund Activity: Q1 2016 in Review
71 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2016, worth a combined $61.3M — down 70% from $203M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CCXI and 10 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 29 added.
The largest buyer was BVF Inc, adding an estimated $5.48M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $8.93M sold.
- 71 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2016, down from 72 in Q4 2015.
- Funds reported $61.3M of ChemoCentryx, Inc. stock for Q1 2016, down 70% quarter-over-quarter.
- 10 funds opened new ChemoCentryx, Inc. positions in Q1 2016 and 11 closed out, a net change of -1 holder.
- The largest ChemoCentryx, Inc. buyer in Q1 2016 was BVF Inc, an estimated $5.48M added.
- The largest ChemoCentryx, Inc. seller in Q1 2016 was Westfield Capital Management, an estimated $8.93M sold.
Based on aggregated 13F filings for Q1 2016.